Status:
WITHDRAWN
Sphenopalatine Ganglion Block for the Treatment of Post-Stroke Headache
Lead Sponsor:
University of Utah
Conditions:
Headache
Stroke
Eligibility:
All Genders
18+ years
Phase:
PHASE2
Brief Summary
Determine the effects of sphenopalatine ganglion (SPG) block in post-stroke headache.
Detailed Description
The purpose of this study is to determine if sphenopalatine ganglion (SPG) block is a safe and effective treatment for acute post-stroke headache. Current literature lacks randomized controlled studie...
Eligibility Criteria
Inclusion
- 18 years or older;
- hospitalization at the University of Utah Hospital with a diagnosis of acute ischemic or hemorrhagic stroke; confirmed acute post-stroke headache by treating physician;
- meets at least one of the following International Classification of Headache Disorder-3 (ICHD-3) criteria: 6.1.1.1 (Acute Headache Attributed to Ischemic Stroke), 6.2.1 (Headache attributed to non-traumatic intracerebral hemorrhage), 6.2.2 (Acute headache attributed to non-traumatic subarachnoid hemorrhage); received at least one medication for headache during hospitalization.
Exclusion
- Previous treatment with SPG Block for post-stroke headache
- history of prophylactic medication use for headache or migraine;
- pregnant at time of stroke
Key Trial Info
Start Date :
March 23 2022
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
June 1 2025
Estimated Enrollment :
Patients enrolled
Trial Details
Trial ID
NCT05365880
Start Date
March 23 2022
End Date
June 1 2025
Last Update
November 13 2024
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
University of Utah
Salt Lake City, Utah, United States, 84108